9
Publications
802
Citations
9
H-Index
2019
Active since
Julien Dilly is an author at Dana-Farber Cancer Institute specializing in tumor biology, pathology, and cell signaling.
Top concepts
MedicineOncologyPathologyCell BiologyTumor BiologyCancer BiologyCell SignalingRadiation Oncology
Publications per year
2019–2025
9
9
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
Matthew Holderfield, Bianca J. Lee, Jingjing Jiang et al. · Nature · 2024 · 268 citations · Full text
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
Julien Dilly, Megan T. Hoffman, Laleh Abbassi et al. · Cancer Discovery · 2024 · 182 citations · Full text
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
Urszula N. Wasko, Jingjing Jiang, Tanner C. Dalton et al. · Nature · 2024 · 150 citations · Full text
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer
Xinyuan Tong, Ayushi S. Patel, Eejung Kim et al. · Cancer Cell · 2024 · 92 citations · Full text
Rows per page
1–5 of 9